{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:08:28Z","timestamp":1774267708661,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,7,6]],"date-time":"2007-07-06T00:00:00Z","timestamp":1183680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2007,11,12]]},"DOI":"10.1007\/s10875-007-9111-1","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T16:29:28Z","timestamp":1183652968000},"page":"557-562","source":"Crossref","is-referenced-by-count":83,"title":["Correction of Th1-dominant Cytokine Profiles by High-dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura"],"prefix":"10.1007","volume":"27","author":[{"given":"Chengshan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,6]]},"reference":[{"key":"9111_CR1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI4238","volume":"102","author":"M Kuwana","year":"1998","unstructured":"Kuwana M, Kaburaki J Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: role in production of anti-platelet autoantibody. J Clin Invest 1998;102:1393\u2013402.","journal-title":"J Clin Invest"},{"key":"9111_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1651-2227.1998.tb01233.x","volume":"424","author":"I Hedlund-Treutiger","year":"1998","unstructured":"Hedlund-Treutiger I, Wahlstrom J, Elinder G. Role of the T cell receptor in idiopathic thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998;424:46\u201350.","journal-title":"Acta Paediatr Suppl"},{"key":"9111_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0955-3886(98)00038-1","volume":"19","author":"JW Semple","year":"1998","unstructured":"Semple JW, Lazarus AH, Freedman J. The cellular immunology associated with autoimmune thrombocytopenic purpura: an update. Transfus Sci 1998;19:245\u201351.","journal-title":"Transfus Sci"},{"key":"9111_CR4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.med.56.082103.104644","volume":"56","author":"DB Cines","year":"2005","unstructured":"Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005;56:425\u201342.","journal-title":"Annu Rev Med"},{"key":"9111_CR5","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V78.10.2619.2619","volume":"78","author":"JW Semple","year":"1991","unstructured":"Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991;78:2619\u201325.","journal-title":"Blood"},{"key":"9111_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2141.1993.tb03102.x","volume":"84","author":"J Garcia-Suarez","year":"1993","unstructured":"Garcia-Suarez J, Prieto A, Reye E, Manzano L, Merino JL, Alvarez-Mon M. The clinical outcome of autoimmune thrombocytopenic purpura is related to their T-cell immunodeficiency. Br J Haematol 1993;84:464\u201370.","journal-title":"Br J Haematol"},{"key":"9111_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01552310","volume":"14","author":"RE Ware","year":"1994","unstructured":"Ware RE, Howard TA. Elevated numbers of gamma delta(\u03b3\u03b4+)T lymphocytes in children with immune thrombocytopenic purpura. J Clin Immunol 1994;14:237\u201347.","journal-title":"J Clin Immunol"},{"key":"9111_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08916939609001950","volume":"24","author":"AR Crossley","year":"1996","unstructured":"Crossley AR, Dickinson AM, Proctor SJ, Calvert JE. Effects of interferon-\u00e1 therapy on immune parameters in immune thrombocytopenic purpura. Autoimmunity 1996;24:81\u2013100.","journal-title":"Autoimmunity"},{"key":"9111_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<119::AID-AJH5>3.0.CO;2-Z","volume":"57","author":"E Erduran","year":"1998","unstructured":"Erduran E, Aslan Y, Aliyazicioglu Y, Mocan H, Gedik Y. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura. Am J Hematol 1998;57:119\u201323.","journal-title":"Am J Hematol"},{"key":"9111_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","volume":"71","author":"H Ogawara","year":"2003","unstructured":"Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, et al. High Th1\/Th2 ratio in patients with chronic autoimmune thrombocytopenic purpura. Eur J Haematol 2003;71:283\u20138.","journal-title":"Eur J Haematol"},{"key":"9111_CR11","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","volume":"103","author":"FP Panitsas","year":"2004","unstructured":"Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 2004;103:2645\u20137.","journal-title":"Blood"},{"key":"9111_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08880010290057345","volume":"19","author":"YA Wali","year":"2002","unstructured":"Wali YA, Al Lamki Z, Shah W, Zacharia M, Hassan A. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 2002;19:329\u201335.","journal-title":"Pediatr Hematol Oncol"},{"key":"9111_CR13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJMoa030254","volume":"349","author":"Y Cheng","year":"2003","unstructured":"Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003;349:831\u20136.","journal-title":"N Engl J Med"},{"key":"9111_CR14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00277-004-0908-1","volume":"83","author":"F Borst","year":"2004","unstructured":"Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol 2004;83:764\u20138.","journal-title":"Ann Hematol"},{"key":"9111_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/07853899808999383","volume":"30","author":"JN George","year":"1998","unstructured":"George JN, Woolf SH, Raskob GE. Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med 1998;30:38\u201344.","journal-title":"Ann Med"},{"key":"9111_CR16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","volume":"120","author":"British Committee for Standards in Haematology","year":"2003","unstructured":"British Committee for Standards in Haematology. General Haematology Task Force: Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574\u201396.","journal-title":"Br J Haematol"},{"key":"9111_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0188-4409(02)00464-2","volume":"34","author":"GR Gutierrez-Espindola","year":"2003","unstructured":"Gutierrez-Espindola GR, Morales-Polanco MR, Guerrero-Rivera S, Talavera JO, Sanchez-Valle E, Gomez-Morales E, et al. High doses of dexamethasone in adult patients with idiopathic thrombocytopenic purpura. Arch Med Res 2003;34:31\u20134.","journal-title":"Arch Med Res"},{"issue":"4","key":"9111_CR18","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood-2005-12-015222","volume":"109","author":"MG Mazzucconi","year":"2007","unstructured":"Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura. A GIMEMA experience. Blood 2007;109(4):1401\u20137.","journal-title":"Blood"},{"key":"9111_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1651-2227.1998.tb01237.x","volume":"424","author":"J Andersson","year":"1998","unstructured":"Andersson J. Cytokines in idiopathic thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998;424:61\u20134.","journal-title":"Acta Paediatr Suppl"},{"key":"9111_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1034\/j.1600-0609.2000.9o096.x","volume":"64","author":"C Yoshimura","year":"2000","unstructured":"Yoshimura C, Nomura S, Nagahama M, Ozaki Y, Kagawa H, Fukuhara S. Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura. Eur J Haematol 2000;64:219\u201324.","journal-title":"Eur J Haematol"},{"key":"9111_CR21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s002770000177","volume":"79","author":"PO Andersson","year":"2000","unstructured":"Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H. A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol 2000;79:507\u201313.","journal-title":"Ann Hematol"},{"key":"9111_CR22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.0007-1048.2002.03345.x","volume":"116","author":"PO Andersson","year":"2002","unstructured":"Andersson PO, Olsson A, Wadenvik H. Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura. Br J Haematol 2002;116:862\u20137.","journal-title":"Br J Haematol"},{"key":"9111_CR23","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/ar1951","volume":"8","author":"M Jackson","year":"2006","unstructured":"Jackson M, Ahmad Y, Bruce IN, Coupes B, Brenchley PE. Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus. Arthritis Res 2006;8:R81.","journal-title":"Arthritis Res"},{"key":"9111_CR24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/107999001750133159","volume":"21","author":"SK Agarwal","year":"2001","unstructured":"Agarwal SK, Marshall GD Jr. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 2001;21:147\u201355.","journal-title":"J Interferon Cytokine Res"},{"key":"9111_CR25","first-page":"914","volume":"90","author":"T Wang","year":"2005","unstructured":"Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, et al. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 2005;90:914\u201323.","journal-title":"Haematologica"},{"key":"9111_CR26","doi-asserted-by":"crossref","first-page":"C331","DOI":"10.1152\/ajpcell.1995.268.2.C331","volume":"37","author":"IM Adcock","year":"1995","unstructured":"Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ. The effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 1995;37:C331.","journal-title":"Am J Physiol"},{"key":"9111_CR27","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood-2002-06-1666","volume":"101","author":"J Peng","year":"2003","unstructured":"Peng J, Liu CF, Liu D, Ren C, Li W, Wang Z, et al. Effects of B7-blocking agent and\/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. Blood 2003;101:2721\u20136.","journal-title":"Blood"},{"key":"9111_CR28","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.4049\/jimmunol.160.5.2231","volume":"160","author":"RH DeKruyff","year":"1998","unstructured":"DeKruyff RH, Fang Y, Umetsu DT. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J Immunol 1998;160:2231\u20137.","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9111-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-007-9111-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9111-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T19:39:29Z","timestamp":1708025969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-007-9111-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11,12]]}},"alternative-id":["9111"],"URL":"https:\/\/doi.org\/10.1007\/s10875-007-9111-1","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,6]]}}}